# China NMPA Drug Inspection - Sinopharm Group Weichida Pharmaceutical Co., Ltd. - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-weichida-pharmaceutical-co-ltd/9c8dddc9-2e53-44af-8259-6ca26c7afaac/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Weichida Pharmaceutical Co., Ltd. published November 11, 2021. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Sinopharm Group Weichida Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-weichida-pharmaceutical-co-ltd/d9607df5-79a1-456e-8c90-66c08beb1fca/